1. Home
  2. GROV vs IRD Comparison

GROV vs IRD Comparison

Compare GROV & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROV
  • IRD
  • Stock Information
  • Founded
  • GROV 2016
  • IRD 2018
  • Country
  • GROV United States
  • IRD United States
  • Employees
  • GROV N/A
  • IRD N/A
  • Industry
  • GROV Package Goods/Cosmetics
  • IRD
  • Sector
  • GROV Consumer Discretionary
  • IRD
  • Exchange
  • GROV Nasdaq
  • IRD NYSE
  • Market Cap
  • GROV 42.2M
  • IRD 38.8M
  • IPO Year
  • GROV N/A
  • IRD N/A
  • Fundamental
  • Price
  • GROV $1.18
  • IRD $0.95
  • Analyst Decision
  • GROV Buy
  • IRD Strong Buy
  • Analyst Count
  • GROV 1
  • IRD 2
  • Target Price
  • GROV $2.00
  • IRD $7.00
  • AVG Volume (30 Days)
  • GROV 48.4K
  • IRD 184.2K
  • Earning Date
  • GROV 05-14-2025
  • IRD 05-15-2025
  • Dividend Yield
  • GROV N/A
  • IRD N/A
  • EPS Growth
  • GROV N/A
  • IRD N/A
  • EPS
  • GROV N/A
  • IRD N/A
  • Revenue
  • GROV $203,425,000.00
  • IRD $10,992,000.00
  • Revenue This Year
  • GROV N/A
  • IRD $22.00
  • Revenue Next Year
  • GROV $6.19
  • IRD $100.89
  • P/E Ratio
  • GROV N/A
  • IRD N/A
  • Revenue Growth
  • GROV N/A
  • IRD N/A
  • 52 Week Low
  • GROV $1.02
  • IRD $0.65
  • 52 Week High
  • GROV $1.95
  • IRD $2.18
  • Technical
  • Relative Strength Index (RSI)
  • GROV 49.41
  • IRD N/A
  • Support Level
  • GROV $1.08
  • IRD N/A
  • Resistance Level
  • GROV $1.19
  • IRD N/A
  • Average True Range (ATR)
  • GROV 0.05
  • IRD 0.00
  • MACD
  • GROV 0.03
  • IRD 0.00
  • Stochastic Oscillator
  • GROV 92.86
  • IRD 0.00

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: